Global Medical Isotopes Market

Medical Isotopes Comprehensive Study by Type (Reactor isotopes (molybdeen-99, xenon-133, holmium-166, lutetium-177, iodine-125, iridium-192, and Others), Cyclotron isotopes (indium-111, iodine-123, thallium-201, rubidium-82, and rubidium-82)), Application (Detect (diagnosis) and treat (therapy) ., Cardiovascular diseases and cancer.), Treatment (Diagnostic, Brachytherapy, Therapy, Pain management), Disease (Heart function, Breast Cancer, Prostate Cancer, Bone Cancer), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals and Diagnostic Centers, Others) Players and Region - Global Market Outlook to 2030

Medical Isotopes Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Medical Isotopes Market Overview:
Medical isotopes are radioactive substances used in the diagnosis and treatment of diseases. The energy emitted by these radioactive substances can be detected using special cameras and imaging software that helps evaluate organ size, location, and function. In treatment, some radioactive substances can be used to destroy harmful cells or tumors. The majority of medical isotopes are made in nuclear reactors with some being produced in cyclotrons. The isotopes that are neutron-rich and those created from nuclear fission must be made in nuclear reactors.

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Increasing Interest in the Innovative Treatment using Holmium-166

Market Growth Drivers:
Increase In R&D Activities In The Pharmaceutical And Biotechnology Sector and Rising Prevalence of the Chronic Diseases like Cancers

Challenges:
Dearth of Skilled Professionals

Restraints:
High Cost of Medical Isotopes Compounds

Opportunities:
Rising Investments in Pharmaceutical R&D in Emerging Markets

Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Northwest Medical Isotopes, LLC (United States), BWX Technologies, Inc. (United States), Coquí RadioPharmaceuticals (United States), Cambridge Isotope Laboratories, Inc. (United States), Merck KGaA (Germany), Urenco Limited (United Kingdom), Isosciences, LLC (An Mdp Chemicals Company) (United States), Medical Isotopes, Inc. (United States), Omicron Biochemicals, Inc. (United States), Nordion Inc. (A Sterigenics International LLC Company) (Canada), Trace Sciences International (Canada), Alsachim (France) and Taiyo Nippon Sanso Corporation (Japan). Additionally, following companies can also be profiled that are part of our coverage like Rotem Industries Israel Ltd (Israel) and Perkinelmer Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Medical Isotopes market by 2030. Considering Market by Treatment, the sub-segment i.e. Diagnostic will boost the Medical Isotopes market. Considering Market by Disease, the sub-segment i.e. Heart function will boost the Medical Isotopes market. Considering Market by End User, the sub-segment i.e. Pharmaceutical & Biotechnology Companies will boost the Medical Isotopes market.

Latest Market Insights:
In April 2018,BWX Technologies, Inc. announced today that it has signed a definitive agreement to acquire Sotera Health’s Nordion medical isotope business.

In November , 2023,BWXT Medical Ltd. and Fusion Pharmaceuticals Inc. announced that the companies have entered into an agreement for the supply of generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.

What Can be Explored with the Medical Isotopes Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Medical Isotopes Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Medical Isotopes
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Medical Isotopes market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Medical Isotopes market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Medical Isotopes Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Reactor isotopes (molybdeen-99, xenon-133, holmium-166, lutetium-177, iodine-125, iridium-192, and Others)
  • Cyclotron isotopes (indium-111, iodine-123, thallium-201, rubidium-82, and rubidium-82)
By Application
  • detect (diagnosis) and treat (therapy) .
  • cardiovascular diseases and cancer.
By Treatment
  • Diagnostic
  • Brachytherapy
  • Therapy
  • Pain management

By Disease
  • Heart function
  • Breast Cancer
  • Prostate Cancer
  • Bone Cancer

By End User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals and Diagnostic Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase In R&D Activities In The Pharmaceutical And Biotechnology Sector
      • 3.2.2. Rising Prevalence of the Chronic Diseases like Cancers
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increasing Interest in the Innovative Treatment using Holmium-166
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medical Isotopes, by Type, Application, Treatment, Disease, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Medical Isotopes (Value)
      • 5.2.1. Global Medical Isotopes by: Type (Value)
        • 5.2.1.1. Reactor isotopes (molybdeen-99, xenon-133, holmium-166, lutetium-177, iodine-125, iridium-192, and Others)
        • 5.2.1.2. Cyclotron isotopes (indium-111, iodine-123, thallium-201, rubidium-82, and rubidium-82)
      • 5.2.2. Global Medical Isotopes by: Application (Value)
        • 5.2.2.1. Detect (diagnosis) and treat (therapy) .
        • 5.2.2.2. Cardiovascular diseases and cancer.
      • 5.2.3. Global Medical Isotopes by: Treatment (Value)
        • 5.2.3.1. Diagnostic
        • 5.2.3.2. Brachytherapy
        • 5.2.3.3. Therapy
        • 5.2.3.4. Pain management
      • 5.2.4. Global Medical Isotopes by: Disease (Value)
        • 5.2.4.1. Heart function
        • 5.2.4.2. Breast Cancer
        • 5.2.4.3. Prostate Cancer
        • 5.2.4.4. Bone Cancer
      • 5.2.5. Global Medical Isotopes by: End User (Value)
        • 5.2.5.1. Pharmaceutical & Biotechnology Companies
        • 5.2.5.2. Academic & Research Institutes
        • 5.2.5.3. Hospitals and Diagnostic Centers
        • 5.2.5.4. Others
      • 5.2.6. Global Medical Isotopes Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Medical Isotopes: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Northwest Medical Isotopes, LLC (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BWX Technologies, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Coquí RadioPharmaceuticals (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cambridge Isotope Laboratories, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck KGaA (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Urenco Limited (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Isosciences, LLC (An Mdp Chemicals Company) (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medical Isotopes, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Omicron Biochemicals, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Nordion Inc. (A Sterigenics International LLC Company) (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Trace Sciences International (Canada)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Alsachim (France)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Taiyo Nippon Sanso Corporation (Japan)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Medical Isotopes Sale, by Type, Application, Treatment, Disease, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Medical Isotopes (Value)
      • 7.2.1. Global Medical Isotopes by: Type (Value)
        • 7.2.1.1. Reactor isotopes (molybdeen-99, xenon-133, holmium-166, lutetium-177, iodine-125, iridium-192, and Others)
        • 7.2.1.2. Cyclotron isotopes (indium-111, iodine-123, thallium-201, rubidium-82, and rubidium-82)
      • 7.2.2. Global Medical Isotopes by: Application (Value)
        • 7.2.2.1. Detect (diagnosis) and treat (therapy) .
        • 7.2.2.2. Cardiovascular diseases and cancer.
      • 7.2.3. Global Medical Isotopes by: Treatment (Value)
        • 7.2.3.1. Diagnostic
        • 7.2.3.2. Brachytherapy
        • 7.2.3.3. Therapy
        • 7.2.3.4. Pain management
      • 7.2.4. Global Medical Isotopes by: Disease (Value)
        • 7.2.4.1. Heart function
        • 7.2.4.2. Breast Cancer
        • 7.2.4.3. Prostate Cancer
        • 7.2.4.4. Bone Cancer
      • 7.2.5. Global Medical Isotopes by: End User (Value)
        • 7.2.5.1. Pharmaceutical & Biotechnology Companies
        • 7.2.5.2. Academic & Research Institutes
        • 7.2.5.3. Hospitals and Diagnostic Centers
        • 7.2.5.4. Others
      • 7.2.6. Global Medical Isotopes Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medical Isotopes: by Type(USD Million)
  • Table 2. Medical Isotopes Reactor isotopes (molybdeen-99, xenon-133, holmium-166, lutetium-177, iodine-125, iridium-192, and Others) , by Region USD Million (2018-2023)
  • Table 3. Medical Isotopes Cyclotron isotopes (indium-111, iodine-123, thallium-201, rubidium-82, and rubidium-82) , by Region USD Million (2018-2023)
  • Table 4. Medical Isotopes: by Application(USD Million)
  • Table 5. Medical Isotopes Detect (diagnosis) and treat (therapy) . , by Region USD Million (2018-2023)
  • Table 6. Medical Isotopes Cardiovascular diseases and cancer. , by Region USD Million (2018-2023)
  • Table 7. Medical Isotopes: by Treatment(USD Million)
  • Table 8. Medical Isotopes Diagnostic , by Region USD Million (2018-2023)
  • Table 9. Medical Isotopes Brachytherapy , by Region USD Million (2018-2023)
  • Table 10. Medical Isotopes Therapy , by Region USD Million (2018-2023)
  • Table 11. Medical Isotopes Pain management , by Region USD Million (2018-2023)
  • Table 12. Medical Isotopes: by Disease(USD Million)
  • Table 13. Medical Isotopes Heart function , by Region USD Million (2018-2023)
  • Table 14. Medical Isotopes Breast Cancer , by Region USD Million (2018-2023)
  • Table 15. Medical Isotopes Prostate Cancer , by Region USD Million (2018-2023)
  • Table 16. Medical Isotopes Bone Cancer , by Region USD Million (2018-2023)
  • Table 17. Medical Isotopes: by End User(USD Million)
  • Table 18. Medical Isotopes Pharmaceutical & Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 19. Medical Isotopes Academic & Research Institutes , by Region USD Million (2018-2023)
  • Table 20. Medical Isotopes Hospitals and Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 21. Medical Isotopes Others , by Region USD Million (2018-2023)
  • Table 22. South America Medical Isotopes, by Country USD Million (2018-2023)
  • Table 23. South America Medical Isotopes, by Type USD Million (2018-2023)
  • Table 24. South America Medical Isotopes, by Application USD Million (2018-2023)
  • Table 25. South America Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 26. South America Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 27. South America Medical Isotopes, by End User USD Million (2018-2023)
  • Table 28. Brazil Medical Isotopes, by Type USD Million (2018-2023)
  • Table 29. Brazil Medical Isotopes, by Application USD Million (2018-2023)
  • Table 30. Brazil Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 31. Brazil Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 32. Brazil Medical Isotopes, by End User USD Million (2018-2023)
  • Table 33. Argentina Medical Isotopes, by Type USD Million (2018-2023)
  • Table 34. Argentina Medical Isotopes, by Application USD Million (2018-2023)
  • Table 35. Argentina Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 36. Argentina Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 37. Argentina Medical Isotopes, by End User USD Million (2018-2023)
  • Table 38. Rest of South America Medical Isotopes, by Type USD Million (2018-2023)
  • Table 39. Rest of South America Medical Isotopes, by Application USD Million (2018-2023)
  • Table 40. Rest of South America Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 41. Rest of South America Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 42. Rest of South America Medical Isotopes, by End User USD Million (2018-2023)
  • Table 43. Asia Pacific Medical Isotopes, by Country USD Million (2018-2023)
  • Table 44. Asia Pacific Medical Isotopes, by Type USD Million (2018-2023)
  • Table 45. Asia Pacific Medical Isotopes, by Application USD Million (2018-2023)
  • Table 46. Asia Pacific Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 47. Asia Pacific Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 48. Asia Pacific Medical Isotopes, by End User USD Million (2018-2023)
  • Table 49. China Medical Isotopes, by Type USD Million (2018-2023)
  • Table 50. China Medical Isotopes, by Application USD Million (2018-2023)
  • Table 51. China Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 52. China Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 53. China Medical Isotopes, by End User USD Million (2018-2023)
  • Table 54. Japan Medical Isotopes, by Type USD Million (2018-2023)
  • Table 55. Japan Medical Isotopes, by Application USD Million (2018-2023)
  • Table 56. Japan Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 57. Japan Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 58. Japan Medical Isotopes, by End User USD Million (2018-2023)
  • Table 59. India Medical Isotopes, by Type USD Million (2018-2023)
  • Table 60. India Medical Isotopes, by Application USD Million (2018-2023)
  • Table 61. India Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 62. India Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 63. India Medical Isotopes, by End User USD Million (2018-2023)
  • Table 64. South Korea Medical Isotopes, by Type USD Million (2018-2023)
  • Table 65. South Korea Medical Isotopes, by Application USD Million (2018-2023)
  • Table 66. South Korea Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 67. South Korea Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 68. South Korea Medical Isotopes, by End User USD Million (2018-2023)
  • Table 69. Taiwan Medical Isotopes, by Type USD Million (2018-2023)
  • Table 70. Taiwan Medical Isotopes, by Application USD Million (2018-2023)
  • Table 71. Taiwan Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 72. Taiwan Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 73. Taiwan Medical Isotopes, by End User USD Million (2018-2023)
  • Table 74. Australia Medical Isotopes, by Type USD Million (2018-2023)
  • Table 75. Australia Medical Isotopes, by Application USD Million (2018-2023)
  • Table 76. Australia Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 77. Australia Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 78. Australia Medical Isotopes, by End User USD Million (2018-2023)
  • Table 79. Rest of Asia-Pacific Medical Isotopes, by Type USD Million (2018-2023)
  • Table 80. Rest of Asia-Pacific Medical Isotopes, by Application USD Million (2018-2023)
  • Table 81. Rest of Asia-Pacific Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Medical Isotopes, by End User USD Million (2018-2023)
  • Table 84. Europe Medical Isotopes, by Country USD Million (2018-2023)
  • Table 85. Europe Medical Isotopes, by Type USD Million (2018-2023)
  • Table 86. Europe Medical Isotopes, by Application USD Million (2018-2023)
  • Table 87. Europe Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 88. Europe Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 89. Europe Medical Isotopes, by End User USD Million (2018-2023)
  • Table 90. Germany Medical Isotopes, by Type USD Million (2018-2023)
  • Table 91. Germany Medical Isotopes, by Application USD Million (2018-2023)
  • Table 92. Germany Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 93. Germany Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 94. Germany Medical Isotopes, by End User USD Million (2018-2023)
  • Table 95. France Medical Isotopes, by Type USD Million (2018-2023)
  • Table 96. France Medical Isotopes, by Application USD Million (2018-2023)
  • Table 97. France Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 98. France Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 99. France Medical Isotopes, by End User USD Million (2018-2023)
  • Table 100. Italy Medical Isotopes, by Type USD Million (2018-2023)
  • Table 101. Italy Medical Isotopes, by Application USD Million (2018-2023)
  • Table 102. Italy Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 103. Italy Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 104. Italy Medical Isotopes, by End User USD Million (2018-2023)
  • Table 105. United Kingdom Medical Isotopes, by Type USD Million (2018-2023)
  • Table 106. United Kingdom Medical Isotopes, by Application USD Million (2018-2023)
  • Table 107. United Kingdom Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 108. United Kingdom Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 109. United Kingdom Medical Isotopes, by End User USD Million (2018-2023)
  • Table 110. Netherlands Medical Isotopes, by Type USD Million (2018-2023)
  • Table 111. Netherlands Medical Isotopes, by Application USD Million (2018-2023)
  • Table 112. Netherlands Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 113. Netherlands Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 114. Netherlands Medical Isotopes, by End User USD Million (2018-2023)
  • Table 115. Rest of Europe Medical Isotopes, by Type USD Million (2018-2023)
  • Table 116. Rest of Europe Medical Isotopes, by Application USD Million (2018-2023)
  • Table 117. Rest of Europe Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 118. Rest of Europe Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 119. Rest of Europe Medical Isotopes, by End User USD Million (2018-2023)
  • Table 120. MEA Medical Isotopes, by Country USD Million (2018-2023)
  • Table 121. MEA Medical Isotopes, by Type USD Million (2018-2023)
  • Table 122. MEA Medical Isotopes, by Application USD Million (2018-2023)
  • Table 123. MEA Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 124. MEA Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 125. MEA Medical Isotopes, by End User USD Million (2018-2023)
  • Table 126. Middle East Medical Isotopes, by Type USD Million (2018-2023)
  • Table 127. Middle East Medical Isotopes, by Application USD Million (2018-2023)
  • Table 128. Middle East Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 129. Middle East Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 130. Middle East Medical Isotopes, by End User USD Million (2018-2023)
  • Table 131. Africa Medical Isotopes, by Type USD Million (2018-2023)
  • Table 132. Africa Medical Isotopes, by Application USD Million (2018-2023)
  • Table 133. Africa Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 134. Africa Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 135. Africa Medical Isotopes, by End User USD Million (2018-2023)
  • Table 136. North America Medical Isotopes, by Country USD Million (2018-2023)
  • Table 137. North America Medical Isotopes, by Type USD Million (2018-2023)
  • Table 138. North America Medical Isotopes, by Application USD Million (2018-2023)
  • Table 139. North America Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 140. North America Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 141. North America Medical Isotopes, by End User USD Million (2018-2023)
  • Table 142. United States Medical Isotopes, by Type USD Million (2018-2023)
  • Table 143. United States Medical Isotopes, by Application USD Million (2018-2023)
  • Table 144. United States Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 145. United States Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 146. United States Medical Isotopes, by End User USD Million (2018-2023)
  • Table 147. Canada Medical Isotopes, by Type USD Million (2018-2023)
  • Table 148. Canada Medical Isotopes, by Application USD Million (2018-2023)
  • Table 149. Canada Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 150. Canada Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 151. Canada Medical Isotopes, by End User USD Million (2018-2023)
  • Table 152. Mexico Medical Isotopes, by Type USD Million (2018-2023)
  • Table 153. Mexico Medical Isotopes, by Application USD Million (2018-2023)
  • Table 154. Mexico Medical Isotopes, by Treatment USD Million (2018-2023)
  • Table 155. Mexico Medical Isotopes, by Disease USD Million (2018-2023)
  • Table 156. Mexico Medical Isotopes, by End User USD Million (2018-2023)
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Medical Isotopes: by Type(USD Million)
  • Table 171. Medical Isotopes Reactor isotopes (molybdeen-99, xenon-133, holmium-166, lutetium-177, iodine-125, iridium-192, and Others) , by Region USD Million (2025-2030)
  • Table 172. Medical Isotopes Cyclotron isotopes (indium-111, iodine-123, thallium-201, rubidium-82, and rubidium-82) , by Region USD Million (2025-2030)
  • Table 173. Medical Isotopes: by Application(USD Million)
  • Table 174. Medical Isotopes Detect (diagnosis) and treat (therapy) . , by Region USD Million (2025-2030)
  • Table 175. Medical Isotopes Cardiovascular diseases and cancer. , by Region USD Million (2025-2030)
  • Table 176. Medical Isotopes: by Treatment(USD Million)
  • Table 177. Medical Isotopes Diagnostic , by Region USD Million (2025-2030)
  • Table 178. Medical Isotopes Brachytherapy , by Region USD Million (2025-2030)
  • Table 179. Medical Isotopes Therapy , by Region USD Million (2025-2030)
  • Table 180. Medical Isotopes Pain management , by Region USD Million (2025-2030)
  • Table 181. Medical Isotopes: by Disease(USD Million)
  • Table 182. Medical Isotopes Heart function , by Region USD Million (2025-2030)
  • Table 183. Medical Isotopes Breast Cancer , by Region USD Million (2025-2030)
  • Table 184. Medical Isotopes Prostate Cancer , by Region USD Million (2025-2030)
  • Table 185. Medical Isotopes Bone Cancer , by Region USD Million (2025-2030)
  • Table 186. Medical Isotopes: by End User(USD Million)
  • Table 187. Medical Isotopes Pharmaceutical & Biotechnology Companies , by Region USD Million (2025-2030)
  • Table 188. Medical Isotopes Academic & Research Institutes , by Region USD Million (2025-2030)
  • Table 189. Medical Isotopes Hospitals and Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 190. Medical Isotopes Others , by Region USD Million (2025-2030)
  • Table 191. South America Medical Isotopes, by Country USD Million (2025-2030)
  • Table 192. South America Medical Isotopes, by Type USD Million (2025-2030)
  • Table 193. South America Medical Isotopes, by Application USD Million (2025-2030)
  • Table 194. South America Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 195. South America Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 196. South America Medical Isotopes, by End User USD Million (2025-2030)
  • Table 197. Brazil Medical Isotopes, by Type USD Million (2025-2030)
  • Table 198. Brazil Medical Isotopes, by Application USD Million (2025-2030)
  • Table 199. Brazil Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 200. Brazil Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 201. Brazil Medical Isotopes, by End User USD Million (2025-2030)
  • Table 202. Argentina Medical Isotopes, by Type USD Million (2025-2030)
  • Table 203. Argentina Medical Isotopes, by Application USD Million (2025-2030)
  • Table 204. Argentina Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 205. Argentina Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 206. Argentina Medical Isotopes, by End User USD Million (2025-2030)
  • Table 207. Rest of South America Medical Isotopes, by Type USD Million (2025-2030)
  • Table 208. Rest of South America Medical Isotopes, by Application USD Million (2025-2030)
  • Table 209. Rest of South America Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 210. Rest of South America Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 211. Rest of South America Medical Isotopes, by End User USD Million (2025-2030)
  • Table 212. Asia Pacific Medical Isotopes, by Country USD Million (2025-2030)
  • Table 213. Asia Pacific Medical Isotopes, by Type USD Million (2025-2030)
  • Table 214. Asia Pacific Medical Isotopes, by Application USD Million (2025-2030)
  • Table 215. Asia Pacific Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 216. Asia Pacific Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 217. Asia Pacific Medical Isotopes, by End User USD Million (2025-2030)
  • Table 218. China Medical Isotopes, by Type USD Million (2025-2030)
  • Table 219. China Medical Isotopes, by Application USD Million (2025-2030)
  • Table 220. China Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 221. China Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 222. China Medical Isotopes, by End User USD Million (2025-2030)
  • Table 223. Japan Medical Isotopes, by Type USD Million (2025-2030)
  • Table 224. Japan Medical Isotopes, by Application USD Million (2025-2030)
  • Table 225. Japan Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 226. Japan Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 227. Japan Medical Isotopes, by End User USD Million (2025-2030)
  • Table 228. India Medical Isotopes, by Type USD Million (2025-2030)
  • Table 229. India Medical Isotopes, by Application USD Million (2025-2030)
  • Table 230. India Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 231. India Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 232. India Medical Isotopes, by End User USD Million (2025-2030)
  • Table 233. South Korea Medical Isotopes, by Type USD Million (2025-2030)
  • Table 234. South Korea Medical Isotopes, by Application USD Million (2025-2030)
  • Table 235. South Korea Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 236. South Korea Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 237. South Korea Medical Isotopes, by End User USD Million (2025-2030)
  • Table 238. Taiwan Medical Isotopes, by Type USD Million (2025-2030)
  • Table 239. Taiwan Medical Isotopes, by Application USD Million (2025-2030)
  • Table 240. Taiwan Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 241. Taiwan Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 242. Taiwan Medical Isotopes, by End User USD Million (2025-2030)
  • Table 243. Australia Medical Isotopes, by Type USD Million (2025-2030)
  • Table 244. Australia Medical Isotopes, by Application USD Million (2025-2030)
  • Table 245. Australia Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 246. Australia Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 247. Australia Medical Isotopes, by End User USD Million (2025-2030)
  • Table 248. Rest of Asia-Pacific Medical Isotopes, by Type USD Million (2025-2030)
  • Table 249. Rest of Asia-Pacific Medical Isotopes, by Application USD Million (2025-2030)
  • Table 250. Rest of Asia-Pacific Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 251. Rest of Asia-Pacific Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 252. Rest of Asia-Pacific Medical Isotopes, by End User USD Million (2025-2030)
  • Table 253. Europe Medical Isotopes, by Country USD Million (2025-2030)
  • Table 254. Europe Medical Isotopes, by Type USD Million (2025-2030)
  • Table 255. Europe Medical Isotopes, by Application USD Million (2025-2030)
  • Table 256. Europe Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 257. Europe Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 258. Europe Medical Isotopes, by End User USD Million (2025-2030)
  • Table 259. Germany Medical Isotopes, by Type USD Million (2025-2030)
  • Table 260. Germany Medical Isotopes, by Application USD Million (2025-2030)
  • Table 261. Germany Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 262. Germany Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 263. Germany Medical Isotopes, by End User USD Million (2025-2030)
  • Table 264. France Medical Isotopes, by Type USD Million (2025-2030)
  • Table 265. France Medical Isotopes, by Application USD Million (2025-2030)
  • Table 266. France Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 267. France Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 268. France Medical Isotopes, by End User USD Million (2025-2030)
  • Table 269. Italy Medical Isotopes, by Type USD Million (2025-2030)
  • Table 270. Italy Medical Isotopes, by Application USD Million (2025-2030)
  • Table 271. Italy Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 272. Italy Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 273. Italy Medical Isotopes, by End User USD Million (2025-2030)
  • Table 274. United Kingdom Medical Isotopes, by Type USD Million (2025-2030)
  • Table 275. United Kingdom Medical Isotopes, by Application USD Million (2025-2030)
  • Table 276. United Kingdom Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 277. United Kingdom Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 278. United Kingdom Medical Isotopes, by End User USD Million (2025-2030)
  • Table 279. Netherlands Medical Isotopes, by Type USD Million (2025-2030)
  • Table 280. Netherlands Medical Isotopes, by Application USD Million (2025-2030)
  • Table 281. Netherlands Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 282. Netherlands Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 283. Netherlands Medical Isotopes, by End User USD Million (2025-2030)
  • Table 284. Rest of Europe Medical Isotopes, by Type USD Million (2025-2030)
  • Table 285. Rest of Europe Medical Isotopes, by Application USD Million (2025-2030)
  • Table 286. Rest of Europe Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 287. Rest of Europe Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 288. Rest of Europe Medical Isotopes, by End User USD Million (2025-2030)
  • Table 289. MEA Medical Isotopes, by Country USD Million (2025-2030)
  • Table 290. MEA Medical Isotopes, by Type USD Million (2025-2030)
  • Table 291. MEA Medical Isotopes, by Application USD Million (2025-2030)
  • Table 292. MEA Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 293. MEA Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 294. MEA Medical Isotopes, by End User USD Million (2025-2030)
  • Table 295. Middle East Medical Isotopes, by Type USD Million (2025-2030)
  • Table 296. Middle East Medical Isotopes, by Application USD Million (2025-2030)
  • Table 297. Middle East Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 298. Middle East Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 299. Middle East Medical Isotopes, by End User USD Million (2025-2030)
  • Table 300. Africa Medical Isotopes, by Type USD Million (2025-2030)
  • Table 301. Africa Medical Isotopes, by Application USD Million (2025-2030)
  • Table 302. Africa Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 303. Africa Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 304. Africa Medical Isotopes, by End User USD Million (2025-2030)
  • Table 305. North America Medical Isotopes, by Country USD Million (2025-2030)
  • Table 306. North America Medical Isotopes, by Type USD Million (2025-2030)
  • Table 307. North America Medical Isotopes, by Application USD Million (2025-2030)
  • Table 308. North America Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 309. North America Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 310. North America Medical Isotopes, by End User USD Million (2025-2030)
  • Table 311. United States Medical Isotopes, by Type USD Million (2025-2030)
  • Table 312. United States Medical Isotopes, by Application USD Million (2025-2030)
  • Table 313. United States Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 314. United States Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 315. United States Medical Isotopes, by End User USD Million (2025-2030)
  • Table 316. Canada Medical Isotopes, by Type USD Million (2025-2030)
  • Table 317. Canada Medical Isotopes, by Application USD Million (2025-2030)
  • Table 318. Canada Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 319. Canada Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 320. Canada Medical Isotopes, by End User USD Million (2025-2030)
  • Table 321. Mexico Medical Isotopes, by Type USD Million (2025-2030)
  • Table 322. Mexico Medical Isotopes, by Application USD Million (2025-2030)
  • Table 323. Mexico Medical Isotopes, by Treatment USD Million (2025-2030)
  • Table 324. Mexico Medical Isotopes, by Disease USD Million (2025-2030)
  • Table 325. Mexico Medical Isotopes, by End User USD Million (2025-2030)
  • Table 326. Research Programs/Design for This Report
  • Table 327. Key Data Information from Secondary Sources
  • Table 328. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medical Isotopes: by Type USD Million (2018-2023)
  • Figure 5. Global Medical Isotopes: by Application USD Million (2018-2023)
  • Figure 6. Global Medical Isotopes: by Treatment USD Million (2018-2023)
  • Figure 7. Global Medical Isotopes: by Disease USD Million (2018-2023)
  • Figure 8. Global Medical Isotopes: by End User USD Million (2018-2023)
  • Figure 9. South America Medical Isotopes Share (%), by Country
  • Figure 10. Asia Pacific Medical Isotopes Share (%), by Country
  • Figure 11. Europe Medical Isotopes Share (%), by Country
  • Figure 12. MEA Medical Isotopes Share (%), by Country
  • Figure 13. North America Medical Isotopes Share (%), by Country
  • Figure 14. Global Medical Isotopes share by Players 2023 (%)
  • Figure 15. Global Medical Isotopes share by Players (Top 3) 2023(%)
  • Figure 16. Global Medical Isotopes share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Northwest Medical Isotopes, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 19. Northwest Medical Isotopes, LLC (United States) Revenue: by Geography 2023
  • Figure 20. BWX Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. BWX Technologies, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Coquí RadioPharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 23. Coquí RadioPharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 24. Cambridge Isotope Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Cambridge Isotope Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Merck KGaA (Germany) Revenue: by Geography 2023
  • Figure 28. Urenco Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Urenco Limited (United Kingdom) Revenue: by Geography 2023
  • Figure 30. Isosciences, LLC (An Mdp Chemicals Company) (United States) Revenue, Net Income and Gross profit
  • Figure 31. Isosciences, LLC (An Mdp Chemicals Company) (United States) Revenue: by Geography 2023
  • Figure 32. Medical Isotopes, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Medical Isotopes, Inc. (United States) Revenue: by Geography 2023
  • Figure 34. Omicron Biochemicals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Omicron Biochemicals, Inc. (United States) Revenue: by Geography 2023
  • Figure 36. Nordion Inc. (A Sterigenics International LLC Company) (Canada) Revenue, Net Income and Gross profit
  • Figure 37. Nordion Inc. (A Sterigenics International LLC Company) (Canada) Revenue: by Geography 2023
  • Figure 38. Trace Sciences International (Canada) Revenue, Net Income and Gross profit
  • Figure 39. Trace Sciences International (Canada) Revenue: by Geography 2023
  • Figure 40. Alsachim (France) Revenue, Net Income and Gross profit
  • Figure 41. Alsachim (France) Revenue: by Geography 2023
  • Figure 42. Taiyo Nippon Sanso Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 43. Taiyo Nippon Sanso Corporation (Japan) Revenue: by Geography 2023
  • Figure 44. Global Medical Isotopes: by Type USD Million (2025-2030)
  • Figure 45. Global Medical Isotopes: by Application USD Million (2025-2030)
  • Figure 46. Global Medical Isotopes: by Treatment USD Million (2025-2030)
  • Figure 47. Global Medical Isotopes: by Disease USD Million (2025-2030)
  • Figure 48. Global Medical Isotopes: by End User USD Million (2025-2030)
  • Figure 49. South America Medical Isotopes Share (%), by Country
  • Figure 50. Asia Pacific Medical Isotopes Share (%), by Country
  • Figure 51. Europe Medical Isotopes Share (%), by Country
  • Figure 52. MEA Medical Isotopes Share (%), by Country
  • Figure 53. North America Medical Isotopes Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Northwest Medical Isotopes, LLC (United States)
  • BWX Technologies, Inc. (United States)
  • Coquí RadioPharmaceuticals (United States)
  • Cambridge Isotope Laboratories, Inc. (United States)
  • Merck KGaA (Germany)
  • Urenco Limited (United Kingdom)
  • Isosciences, LLC (An Mdp Chemicals Company) (United States)
  • Medical Isotopes, Inc. (United States)
  • Omicron Biochemicals, Inc. (United States)
  • Nordion Inc. (A Sterigenics International LLC Company) (Canada)
  • Trace Sciences International (Canada)
  • Alsachim (France)
  • Taiyo Nippon Sanso Corporation (Japan)
Additional players considered in the study are as follows:
Rotem Industries Israel Ltd (Israel) , Perkinelmer Inc. (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 221 Pages 69 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medical Isotopes Market Quantitative research analysis
Global Medical Isotopes Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Medical Isotopes market are Northwest Medical Isotopes, LLC (United States), BWX Technologies, Inc. (United States), Coquí RadioPharmaceuticals (United States), Cambridge Isotope Laboratories, Inc. (United States), Merck KGaA (Germany), Urenco Limited (United Kingdom), Isosciences, LLC (An Mdp Chemicals Company) (United States), Medical Isotopes, Inc. (United States), Omicron Biochemicals, Inc. (United States), Nordion Inc. (A Sterigenics International LLC Company) (Canada), Trace Sciences International (Canada), Alsachim (France) and Taiyo Nippon Sanso Corporation (Japan), to name a few.
"Increasing Interest in the Innovative Treatment using Holmium-166" is seen as one of major influencing trends for Medical Isotopes Market during projected period 2023-2030.
Reactor isotopes (molybdeen-99, xenon-133, holmium-166, lutetium-177, iodine-125, iridium-192, and Others) segment in Global market to hold robust market share owing to "Increase In R&D Activities In The Pharmaceutical And Biotechnology Sector ".

Know More About Global Medical Isotopes Market Report?

Have a Query? Click Here

Other Related Reports

Undescended Testicle Diagnosis Comprehensive Study by Treatment (Surgery, Hormone Therapy), Undescended Testes (Congenital and Acquired, Palpable and Non-Palpable, Unilateral or Bilateral), End-Use (...
$ 3800
Uterine Sarcoma Comprehensive Study by Type (Uterine leiomyosarcoma (LMS), Endometrial stromal sarcoma (ESS), Undifferentiated sarcoma), Diagnosis (Surgery, Radiotherapy, Chemotherapy, Hormone t...
$ 3650
Serotonin Syndrome Treatment Comprehensive Study by Type (Medication, Hospitalization), Application (Influencing learning,, Memory,, Happiness as well as regulating body temperature, Sleep,, Sexual b...
$ 3650
Radiation Toxicity Treatment Comprehensive Study by Type (Potassium Iodide (ThyroShield, Iosat), Prussian blue (Radiogardase), Diethylenetriamine pentaacetic acid (DTPA), Others), Application (Hospit...
$ 3750
Swollen Knee Comprehensive Study by Type (Acute Knee Swelling, Chronic Knee Swelling), Treatment (Medications, Surgical Procedures (Arthrocentesis, Arthroscopy and Joint replacement)), End-user (Hosp...
$ 3450
Diabetic Macular Edema Treatment Comprehensive Study by Type (Laser Photocoagulation Therapy, Pharmacological Therapy, Bevacizumab, Ranibizumab, Triamcinolone), Indication (Diffuse Diabetic Macular E...
$ 3750